Breast imaging technologies play a crucial role in diagnosing breast cancer, with nearly half of women over 62 facing this diagnosis, as reported by the American Cancer Society. These technologies aid doctors and surgeons in assessing breast shape, cell composition, and detecting tumors, contributing significantly to reducing breast-related illness fatalities worldwide. Driven by the escalating population of women aged 45 and above, who are at higher risk of breast cancer, the global demand for breast imaging technologies is poised to surge at a 7% CAGR. By 2027, the market is anticipated to reach a valuation of US$ 6.6 billion, reflecting substantial growth from its 2022 value of US$ 4.7 billion.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7709

The Breast Imaging Technologies Market operates within the broader medical imaging sector and is propelled by the imperative for early breast cancer detection. This market thrives on rapid technological advancements, heightened awareness regarding breast health, and the increasing incidence of breast cancer worldwide. Key players consistently innovate to enhance imaging capabilities, improve patient comfort, and streamline workflows, ensuring continuous evolution and improvement within the sector.

Market Dynamics:

The market for breast imaging technologies is primarily driven by the increasing prevalence of breast cancer worldwide. According to the World Health Organization (WHO), breast cancer is the most common cancer among women globally, with approximately 2.3 million new cases diagnosed in 2020 alone. Early detection through screening mammography and other imaging modalities significantly improves survival rates, leading to a higher demand for breast imaging technologies.

Technological advancements in breast imaging, such as digital mammography, breast MRI, and tomosynthesis, have also contributed to market growth. These technologies offer higher sensitivity and specificity compared to traditional mammography, leading to more accurate diagnoses. Additionally, the growing trend towards personalized medicine and the integration of artificial intelligence (AI) in breast imaging are expected to further drive market growth.

Key Takeaways from Market Study

• Demand for breast imaging technologies is expected to rise at a CAGR of 7% through 2027.

• The global breast imaging technologies market is currently valued at US$ 4.7 billion.

• The market in Canada is anticipated to expand at a CAGR of 6.5% over the forecast period.

• Demand for non-ionizing technologies is predicted to increase at a CAGR of 6.9% from 2022 to 2027.

• The market in Germany is set to increase at a CAGR of 4.5% through 2027.

Market Future Outlook:

The breast imaging technologies market is expected to continue growing at a steady pace, driven by factors such as increasing awareness about breast cancer, improving healthcare infrastructure in emerging economies, and ongoing technological advancements. The market is also likely to benefit from the integration of AI and machine learning algorithms, which can help radiologists interpret images more accurately and efficiently.

Rising Demand for Diagnosis of Breast-related Abnormalities

According to Fact.MR, a market research and competitive intelligence provider, sales of breast imaging technologies are expected to increase at a CAGR of 7% from 2022 to 2027.

The risks of breast cancer have considerably grown in recent years due to factors such as the widespread use of hormone replacement therapy after menopause, numerous reproductive issues, and hormonal changes. Breast cancer screening and diagnosis are becoming increasingly popular worldwide due to the rising incidence of breast cancer.

Breast-related abnormalities are diagnosed using breast imaging technologies. Doctors and tumor surgeons can diagnose breast anatomy, cell composition, tumors, and other internal breast components using breast imaging technologies.

Key Players:

• Hologic, Inc.
• Philips Healthcare
• GE Healthcare
• SonoCine, Inc.
• Aurora Imaging Technology, Inc.
• Dilon Technologies, Inc.
• FUJIFILM Holdings Corporation
• Siemens Healthineers
• Toshiba Corporation

Competitive Landscape:

Well-established organizations are implementing innovations and enhancements to improve breast cancer services as the healthcare sector looks for new strategies to provide access to high-quality care. Mid-size to smaller businesses are expanding their market presence by launching new items and minimizing the adverse effects of the treatments due to technological advancements and product improvements.

In 2020, Hologic, Inc. revealed the commercial availability of its AI detection tool to assist radiologists in finding tumors in breast tomosynthesis images. The company claims that it will improve patient experience and enhance cancer diagnosis.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=7709

Segments of Breast Imaging Technologies Industry Research

• By Type :

  • Ionizing Technologies

  • Non-ionizing Technologies

• By End User :

  • Hospitals

  • Diagnostic Imaging Centers

  • Breast Care Centers

  • Others

• By Region :

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com